Pine Haven Investment Counsel Inc Sells 35 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Pine Haven Investment Counsel Inc lessened its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,584 shares of the medical equipment provider’s stock after selling 35 shares during the quarter. Pine Haven Investment Counsel Inc’s holdings in Intuitive Surgical were worth $827,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the company. Godsey & Gibb Inc. grew its position in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. purchased a new stake in shares of Intuitive Surgical during the third quarter valued at $33,000. Decker Retirement Planning Inc. bought a new position in shares of Intuitive Surgical in the fourth quarter worth about $36,000. Capital Performance Advisors LLP purchased a new position in Intuitive Surgical in the 3rd quarter worth about $38,000. Finally, DT Investment Partners LLC lifted its holdings in Intuitive Surgical by 80.0% during the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after buying an additional 36 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages have commented on ISRG. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Citigroup increased their price objective on Intuitive Surgical from $567.00 to $640.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Raymond James increased their price target on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. Finally, Truist Financial lifted their price objective on Intuitive Surgical from $570.00 to $640.00 and gave the company a “buy” rating in a report on Wednesday, December 18th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $554.17.

Insiders Place Their Bets

In other news, EVP Brian Edward Miller sold 2,553 shares of the business’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the sale, the executive vice president now directly owns 7,066 shares of the company’s stock, valued at $3,638,990. The trade was a 26.54 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the firm’s stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares of the company’s stock, valued at $12,391,166.97. This trade represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 48,190 shares of company stock valued at $25,012,927. 0.80% of the stock is currently owned by corporate insiders.

Intuitive Surgical Trading Up 1.5 %

NASDAQ ISRG opened at $592.64 on Monday. The firm’s fifty day simple moving average is $540.66 and its two-hundred day simple moving average is $499.19. The firm has a market capitalization of $211.09 billion, a P/E ratio of 95.28, a P/E/G ratio of 4.66 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $362.14 and a 12-month high of $597.68.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The firm had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. As a group, sell-side analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.